Elbon - instructions for use, reviews, analogs and forms of release (powder for ingestion, injections in ampoules) for the treatment of arthrosis and osteochondrosis in adults, children and pregnancy

In this article, you can read the instructions for using the drug Elbona. Presented are reviews of visitors to the site - consumers of this medication, as well as opinions of doctors of specialists on the use of Elbona in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Elbon analogs in the presence of existing structural analogs. Use for the treatment of arthrosis and osteochondrosis in adults, children, as well as during pregnancy and lactation.

Elbona - a drug that stimulates the process of repair of cartilaginous tissue. Glucosamine sulfate has an anti-inflammatory and analgesic effect, replenishes the endogenous deficiency of glucosamine, stimulates the synthesis of proteoglycans and hyaluronic acid synovial fluid; increases the permeability of the joint capsule, restores enzymatic processes in the cells of the synovial membrane and articular cartilage. Promotes fixation of sulfur during the synthesis of chondroitinsulfuric acid, inhibits the development of degenerative processes in the joints, restores their function, reducing joint pain.

Composition

Glucosamine sodium sulfate chloride + excipients.

Pharmacokinetics

Absorption in the gastrointestinal tract is 90%, bioavailability is 26%.

Indications

• arthrosis of peripheral joints;
• osteoarthritis of the joints of the spine;
• osteochondrosis.

Forms of release

Powder for solution for oral administration.

Solution for intramuscular injection (injections in ampoules for injection).

Instructions for use and reception scheme

Powder

The contents of 1 packet are dissolved in 200 ml of water, taken orally once a day for 6 weeks.

On the appointment of a doctor, the course of treatment can be repeated at intervals of 2 months.

Ampoules

Elbone is injected intramuscularly! The drug is not intended for intravenous administration.

Before administration, a solvent (solution B) with the solution of the preparation (solution A) should be mixed in one syringe. The prepared solution is injected in / m 3 ml (2 ml solution A + 1 ml solution B) 3 times a week for 4-6 weeks.

Side effect

• flatulence;
• diarrhea;
• constipation;
• nausea, vomiting;
• hives;
• itching;
• anaphylactic reactions;
• drowsiness;
• diplopia;
• headache;
• dizziness;
• numbness of the tongue and mucous membrane of the mouth;
• euphoria;
• violation of cardiac conduction.

Contraindications

• phenylketonuria;
• individual hypersensitivity to glucosamine, lidocaine hydrochloride and other components of the drug.

Due to the presence of Lidocaine in the formulation (ampoule form):

• cardiac conduction abnormalities;
• acute heart failure;
• epileptiform cramps in the anamnesis;
• severe violations of the liver and kidneys;
• pregnancy;
• lactation period;
• children under 12 years.

Application in pregnancy and lactation

Contraindicated in the use of Elbon in pregnancy and lactation.

special instructions

With intolerance to seafood (shrimp, shellfish), the likelihood of developing allergic reactions against the backdrop of Elbona is increasing.

Drug Interactions

Compatible with non-steroidal anti-inflammatory agents, Paracetamol and glucocorticosteroids.

Cimetidine and Propranolol reduce hepatic clearance of lidocaine (reduced metabolism due to inhibition of microsomal oxidation and decreased hepatic blood flow) and increase the risk of toxic effects.

When administered with aymalin, phenytoin, verapamil, quinidine, amiodarone, an increase in the negative inotropic effect is possible.

Co-administration with beta-blockers increases the risk of bradycardia.

With a joint appointment, the cardiotonic effect of cardiac glycosides is weakened.

With simultaneous use with muscle relaxants, it is possible to intensify their action.

Procainamide with simultaneous application with lidocaine increases the risk of developing CNS excitement, hallucinations.

With the simultaneous administration of hypnotics and sedatives, it is possible to intensify their inhibitory effect on the central nervous system.

With iv injection of hexobarbital or thiopental sodium on the background of the action of lidocaine, respiratory depression is possible.

Lidocaine potentiates the effects of MAO inhibitors.

When used simultaneously with polymyxin B, the inhibitory effect on neuromuscular transmission may be increased, so in this case it is necessary to monitor the function of the patient's breathing.

Possible decrease in the effectiveness of hypoglycemic drugs, doxorubicin, teniposide, etoposide.

Analogues of Elbon's medicinal product

Structural analogs for the active substance:

• Aminoarthrin;
• Glucosamine;
• Glucosamine sulfate;
• Glucosamine hydrochloride;
• Pharmaskin TGC;
• Unium

Analogues on the therapeutic effect (correctors of cartilage tissue metabolism):

• Alflutop;
• Aminoarthrin;
• Artra Chondroitin;
• Arthrin;
• Biartrin;
• Don;
• Kartilag Vitrum;
• Mukosat;
• Rumalon;
• Sabelnik rhizome;
• Synovial;
• Vitreous body;
• Structum;
• Chondraktiv;
• Chondramine;
• Hondrogaard;
• Chondroglucide;
• Chondroitin;
• Chondroitin sulfate;
• Chondroxide;
• Chondrolife;
• Chondrolon;
• Honsurid.

Similar medicines:

Other medicines: